Clinical Trial Update: A Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC - An Expansion [Phase 2]

View source ↗

Summary

Phase 2 expansion study of AAV2-hAADC gene therapy for aromatic amino acid decarboxylase (AADC) deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aromatic Amino Acid Decarboxylase Deficiency

Drugs mentioned

• AAV2-hAADC (AAV2-hAADC)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Aromatic Amino Acid Decarboxylase Deficiency | Phase 2 | Status: COMPLETED